Children prescribed GLP-1 medications for weight loss, prediabetes or type 2 diabetes are at risk for nutritional deficiencies—diagnosed in nearly one in six patients (16.8%) within the first year—according to a new study published in the journal Childhood Obesity. Vitamin D deficiency was the most common, identified in 12.4% of children within one year of GLP-1 treatment.
❓ Unknown
Study Reveals Nutritional Deficiencies Linked to GLP-1 Medications in Children
Just now
September 22, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
A study published in Childhood Obesity indicates that children in the U.S. prescribed GLP-1 medications for weight management face significant nutritional deficiencies, particularly vitamin D deficiency. This issue highlights potential health risks associated with obesity treatments, which may resonate with Iranian healthcare discussions as obesity rates rise in the country.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
14 min ago •
New Screening Program for Congenital Cytomegalovirus Aims to Prevent Hearing Loss in Infants
14 min ago •
Navigating Childcare: The Struggles of Families with Special Educational Needs in Iran
14 min ago •
Engineered Nanoparticles Enhance Radiotherapy Effectiveness for Gliomas
16 min ago •
Middle East at a Crossroads: Future Implications Following the Iran Conflict
17 min ago •